SORENSEN MEL (President and CEO) purchased 43.1% of their position (100K shares) of GALERA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $168.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/14/2023ACC: 0000899243-23-008289
DirectorOfficer· President and CEO
Since Nov 2019
+100K
Net shares
Net buyer
$168.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
$1.68
Trade value
$168.12K
% of position
43.1%
3/10/2023
232.04K→332.04K
Total
Net shares
+100K
Net value
$168.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/10/2023 | P · Purchase | +100K | $1.68 | $168.12K | 43.1% | 232.04K | 332.04K |
| Total | +100K | $168.12K | ||||||
Derivative Transactions0
No derivative transactions reported